Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph I Dose Escalation & Cohort Expansion Study of TSR-042 in Pts w/ Advanced Solid Tumors

Protocol: OSU-16293

Full Title

A Phase I Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors

Brain Cancer Genitourinary Cancers Endocrine Cancers Gastrointestinal Cancers Gynecologic Cancers Bone Cancer Head & Neck Cancers Skin Cancers Sarcoma Vulvar Cancer Anal Cancer Pituitary Tumor Liver Cancer Merkel Cell Carcinoma Cervical Cancer Squamous Cell Carcinoma Neuroendocrine Cancer Stomach (Gastric) Cancer Endometrial Cancer Testicular Cancer Esophageal Cancer Bone & Spine Sarcoma Skull Base Soft Tissue Sarcoma Laryngeal Cancer Colon Cancer Small Intestine Cancer Oropharyngeal Cancer Bladder Cancer Parathyroid Cancer Pancreatic Cancer Kidney Cancer Ovarian Cancer Ocular Melanoma Multiple Myeloma Gastrointestinal Carcinoid Tumors Breast Cancer Vaginal Cancer Lip & Oral Cavity Cancer Rectal Cancer Gliomas Basal Cell Carcinoma Melanoma Thyroid Cancer Other Brain Cancers Prostate Cancer Gallbladder Cancer Kaposi Sarcoma Spine Tumors Lung Cancers